Women's Cancers
15 ESCO credits
26.04.2013 - 28.04.2013
Ribarska Banja, Serbia
COURSES AND SEMINARS
Description
Chairs: M. Piccart, BE - M. Rosselli Del Turco, IT - J.B. Vermorken, BE
Host chairs: S. Filipović, RS - V. Kesić, RS - S. Vrbić, RS
ESO Balkan Region Co-ordinator: R. Popescu, CH
INTRODUCTION
The Women’s cancers course will focus on the incidence and mortality of these malignancies, comparing the worldwide data with the percentages in Balkan countries, with the ultimate goal to improve the results in the region, from screening to oncologic treatment outcomes, and psychosocial support. The lecturers will be experts in their respective fields, and the participants will get new, updated knowledge and current guidelines, which would greatly help them to resolve the dilemmas they are faced with in their everyday work, both in screening and diagnosis, and in oncologic treatment approaches as well. An outline will be presented of new targeted therapies, already a part of good clinical practice, or those expected in the near future.
LEARNING OBJECTIVES
• Improve knowledge on women cancer data on a worldwide basis (incidence, prevalence, mortality...) compared to the data for the Balkan region
• Update on the current guidelines concerning breast cancer screening and screening of cervical cancer; early diagnosis of breast cancer; cervical, endometrial, and ovarian cancer; genetic profiling; hereditary women cancers; oncologic treatments (surgery, radiation therapy, chemotherapy, and targeted therapy)
• Discuss resolution of the most common everyday practice dilemmas through clinical cases
• Improved knowledge on the psychosocial aspects of women’s cancers
MAIN TOPICS
• Breast cancer
• Gynecologic cancer (cervical, endometrial, and ovarian cancer)
General information
ORGANISING COMMITTEE
S. Ilić, Faculty of Medicine University of Niš
Z. Radovanović, Clinical Center Niš
S. Vrbić, Clinic of Oncology, Clinical Center Niš
S. Filipovic, Clinical Oncology, Faculty of Medicine University of Niš
LOCAL ORGANISING SECRETARIAT
Dragan Trajković
University of Niš, Faculty of Medicine and Clinical Center Niš
Bl Zorana Djindjica 81
18000 Nis
Tel: +381 642087693
Email: medfak_nis@yahoo.com
ORGANISING SECRETARIAT
Roberta Ventura
European School of Oncology (ESO)
Via del Bollo, 4
20123 Milan, Italy
Tel: +39 02 8546 4523
Fax: +39 02 8546 4545
Email: rventura@eso.net
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation in the Course. Participants are advised to take out their own personal and travel insurance coverage.
CME ACCREDITATION AND CERTIFICATES
The 'Women's Cancers' course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The 'Women's Cancers' course is designated for up to 15 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Accredited program of CME by the Decision of the Health Council of the Republic of Serbia No. 153-02-562/2013-01 of 01.03.2013. Passive participation 7 credits, Lecturer 13 credits.
Faculty list
FACULTY
H.A. Azim Jr, Jules Bordet Institute, Brussels, BE
A. Costa, European School of Oncology, Milan, IT
T. Čufer, University Clinic Golnik, SI
S. Đurđević, Clinic of Gynaecology, Clinical Center Novi Sad, RS
R. Džodić, Institute of Oncology and Radiology of Serbia, Belgrade, RS
A. Filipović, Imperial College London, UK
S. Filipović, Faculty of Medicine and Clinic of Oncology, Clinical Center Niš, RS
E. Ilijazović, University Clinical Center, Dept. Pathology, Tuzla, BA
A. Jarić, Institute of Oncology and Radiology of Serbia, Belgrade, RS
A. Jovićević , Institute of Oncology and Radiology of Serbia, Belgrade, RS
S. Kadija, Institute of Obstetrics & Gynaecology, Clinical Center of Serbia, Belgrade, RS
V. Kesić, Institute of Obstetrics & Gynaecology, Clinical Center of Serbia, Belgrade, RS
R. Kimmig, University Hospital of Essen, DE
V. Kovčin, Clinical Center Bezanijska Kosa, Clinic of Oncology, Belgrade, RS
J. Mladenović, Institute of Oncology and Radiology of Serbia, Belgrade, RS
S. Mijalković, Institute of Oncology and Radiology of Serbia, Belgrade, RS
Lj. Muzikravić, Institute of Oncology of Vojvodina, Sremska Kamenica, RS
Z. Nešković, Institute of Oncology and Radiology of Serbia, Belgrade, RS
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
V. Pažin, Clinic of Gynaecology and Obstetrics Narodni front, Belgrade, RS
V. Plešinac, Institute of Oncology and Radiology of Serbia, Belgrade, RS
G. Pruneri, European Institute of Oncology, IT
M. Rosselli del Turco, European Society of Breast Cancer Specialists, (EUSOMA), Florence, IT
Đ. Šarić, National Association of Cancer Treated Patient, Sombor, RS
Lj. Stamatović, Institute of Oncology and Radiology of Serbia, Belgrade, RS
A. Stefanović, Institute of Obstetrics & Gynaecology, Clinical Center of Serbia, Belgrade, RS
P. Stefanovski, Clinical Hospital, Bitola, MK
S. Šušnjar, Institute of Oncology and Radiology of Serbia, Belgrade, RS
S. Vasović, Institute of Oncology and Radiology of Serbia, Belgrade, RS
J. Vermorken, University Hospital Antwerp, BE
S. Vrbić, Clinical Center Niš, RS
Programme
26 April
| BREAST CANCER Chairs: M. Rosselli Del Turco, IT - S. Filipovic, RS | |
| 09:00 | Opening remarks. Importance of Breast Units A. Costa, IT - S. Filipović, RS |
| 09:20 | Breast cancer in young women: Overview M. Piccart, BE - H.A. Azim Jr, BE |
| 10:10 | Coffee break |
| 11:00 | Epidemiology: Worldwide and Balkan women’s cancer data (both breast and gynaecologic cancers) A. Jovićević, RS |
| 11:20 | Breast cancer screening and imaging M. Rosselli Del Turco, IT |
| 11:40 | MRI of breast cancer and new techniques A. Jarić, RS |
| 12:00 | Metastatic breast cancer - Chemotherapy T. Čufer, SI |
| 12:20 | Breast cancer pathology (histopathology & biomarkers): Standard approaches G. Pruneri, IT |
| 12:40 | Breast cancer surgery - Radical R. Džodić, RS |
| 13:00 | Breast cancer surgery - Conservative A. Costa, IT |
| 13:20 | Breast cancer radiation therapy J. Mladenović, RS |
| 13:40 | Panel discussion and questions Moderator: A. Costa, IT |
| 13:50 | Lunch |
| 15:00 | Early/locally advanced breast cancer - Chemotherapy Lj. Stamatović, RS |
| 15:20 | Early/locally advanced breast cancer - Hormonotherapy Z. Nešković, RS |
| 15:40 | Early/locally advanced breast cancer - Targeted therapy P. Stefanovski, MK |
| 16:00 | Requisites of identifying and validating novel translational therapeutic targets A. Filipović, UK |
| 16:20 | Coffee break |
| 16:40 | Metastatic breast cancer - Hormonotherapy Lj. Muzikravić, RS |
| 17:00 | Metastatic breast cancer - Targeted therapy S. Vasović, RS |
| 17:40 | Case reports Moderator: V. Kovčin, RS |
| 20:30 | Social event |
27 April
| GYNAECOLOGICAL CANCER Chairs: J.B. Vermorken, BE - V. Kesić, RS | |
CERVICAL CANCERS | |
09:30 | Screening for cervical cancer - European perspective |
| 09:50 | Surgical therapy of cervical cancer S. Đurđević, RS |
| 10:10 | Radiotherapy in cervical cancer |
| 10:30 | The role of chemotherapy in cervical cancer Lj. Stamatović, RS |
| 11:00 | Case report Moderators: V. Kesić, RS - S. Đurđević, RS - V. Plešinac, RS Lj. Stamatović, RS |
| 11:30 | Coffee break |
| ENDOMETRIAL CANCERS | |
| 12:00 | What is new in the pathology of endometrial cancer E. Ilijazović, 31 |
| 12:30 | Surgery of endometrial cancer R. Kimmig, DE |
| 13:00 | Adjuvant treatment of endometrial cancer J.B. Vermorken, BE |
13:30 | Lunch |
| OVARIAN CANCERS | |
| 14:30 | New frontiers in the diagnosis of ovarian cancer S. Kadija, RS |
| 14:50 | Management of early ovarian cancer V. Pažin, RS |
| 15:10 | The importance of surgery in advanced ovarian cancer A. Stefanović, RS |
| 15:30 | Chemotherapy in ovarian cancer J.B. Vermorken, BE |
| 16:00 | Case report Moderators: S. Kadija, RS - V. Pažin, RS - A. Stefanović, RS J.B. Vermorken, BE |
| 16:30 | Coffee break |
| 17:00 | Robotic surgery in gynaecologic oncology R. Kimmig, DE |
| 17:30 | Psycho-oncology in gynaecologic oncology S. Mijalković, RS |
28 April
| GUIDELINES AND ADVOCACY Chairs: H.A. Azim Jr, BE - S. Filipović, RS - J.B. Vermorken, BE - V. Kesić, RS | |
09:00 | Hereditary women cancers |
| 09:20 | Monitoring disease progression: Waiting for symptoms versus regular follow up? Debate of the two stand-points |
| 09:50 | Official Serbian National Association of Cancer Treated Patients - NALOR Đ. Šarić, RS - V. Bonžić, RS - D. Babić, RS |
| 10:20 | Current guidelines for breast cancer |
| 11:20 | Current ESMO guidelines for gynaecological cancers V. Kesić, RS - J.B. Vermorken, BE |
| 12:50 | Closing remarks |